206 related articles for article (PubMed ID: 31393199)
21. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
[TBL] [Abstract][Full Text] [Related]
22. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
[TBL] [Abstract][Full Text] [Related]
23. PERIVASCULAR FLOWER-BUD-LIKE LESIONS ON EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH VITREORETINAL LYMPHOMA.
Chen W; Gu J; Liu S; Zhao Z; Jiang T; Xu G; Chang Q
Retina; 2022 Nov; 42(11):2169-2175. PubMed ID: 35982514
[TBL] [Abstract][Full Text] [Related]
24. Multimodal Imaging of Vitreoretinal Lymphoma.
Mapelli C; Invernizzi A; Barteselli G; Pellegrini M; Tabacchi E; Staurenghi G; Viola F
Ophthalmologica; 2016; 236(3):166-174. PubMed ID: 27627063
[TBL] [Abstract][Full Text] [Related]
25. INTRAVITREAL MELPHALAN INJECTION AS A SECOND-LINE LOCAL THERAPY IN VITREORETINAL LYMPHOMA: Case Series.
Guneri Beser B; Demirci H
Retina; 2024 Feb; 44(2):353-359. PubMed ID: 37883576
[TBL] [Abstract][Full Text] [Related]
26. Retinal and choroidal changes and visual outcome in central retinal artery occlusion: an optical coherence tomography study.
Ahn SJ; Woo SJ; Park KH; Jung C; Hong JH; Han MK
Am J Ophthalmol; 2015 Apr; 159(4):667-76. PubMed ID: 25579642
[TBL] [Abstract][Full Text] [Related]
27. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration.
Switzer DW; Mendonça LS; Saito M; Zweifel SA; Spaide RF
Retina; 2012 Jul; 32(7):1265-71. PubMed ID: 22222760
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal rituximab monotherapy for management of eyes with vitreoretinal lymphoma: initial experience from India.
Rishi P; Manchegowda PT; Gondhale HP; Rishi E; Das K; Krishnakumar S; Raja T; Biswas J
Int Ophthalmol; 2021 Jul; 41(7):2495-2504. PubMed ID: 33730314
[TBL] [Abstract][Full Text] [Related]
29. Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up.
Maggio E; Bauci F; Polito A; Arena F; Pertile G
BMC Ophthalmol; 2024 Apr; 24(1):194. PubMed ID: 38664667
[TBL] [Abstract][Full Text] [Related]
30. Diabetic retinal pigment epitheliopathy: fundus autofluorescence and spectral-domain optical coherence tomography findings.
Kang EC; Seo Y; Byeon SH
Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):1931-1940. PubMed ID: 27052841
[TBL] [Abstract][Full Text] [Related]
31. Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.
Karasu B; Gunay BO
Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):99-106. PubMed ID: 31768680
[TBL] [Abstract][Full Text] [Related]
32. Features of optical coherence tomography predictive of choroidal neovascularisation treatment response in pathological myopia in association with fluorescein angiography.
Lee DH; Kang HG; Lee SC; Kim M
Br J Ophthalmol; 2018 Feb; 102(2):238-242. PubMed ID: 28600301
[TBL] [Abstract][Full Text] [Related]
33. Use of intravitreal rituximab for treatment of vitreoretinal lymphoma.
Larkin KL; Saboo US; Comer GM; Forooghian F; Mackensen F; Merrill P; Sen HN; Singh A; Essex RW; Lake S; Lim LL; Vasconcelos-Santos DV; Foster CS; Wilson DJ; Smith JR
Br J Ophthalmol; 2014 Jan; 98(1):99-103. PubMed ID: 24158837
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy.
Hanumunthadu D; Matet A; Rasheed MA; Goud A; Vuppurabina KK; Chhablani J
Indian J Ophthalmol; 2019 Nov; 67(11):1850-1854. PubMed ID: 31638047
[TBL] [Abstract][Full Text] [Related]
35. Multimodal imaging of early stage 1 type 3 neovascularization with simultaneous eye-tracked spectral-domain optical coherence tomography and high-speed real-time angiography.
Querques G; Souied EH; Freund KB
Retina; 2013 Oct; 33(9):1881-7. PubMed ID: 23644560
[TBL] [Abstract][Full Text] [Related]
36. Clinical and Genetic Features of Choroideremia in Childhood.
Khan KN; Islam F; Moore AT; Michaelides M
Ophthalmology; 2016 Oct; 123(10):2158-65. PubMed ID: 27506488
[TBL] [Abstract][Full Text] [Related]
37. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.
Miere A; Querques G; Semoun O; Amoroso F; Zambrowski O; Chapron T; Capuano V; Souied EH
Retina; 2017 Oct; 37(10):1873-1879. PubMed ID: 28079756
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal Ziv-Aflibercept : Safety Analysis in Eyes Receiving More Than Ten Intravitreal Injections.
Singh SR; Chattannavar G; Ayachit A; Pimentel MC; Alfaro A; Tiwari S; Heranjal A; Subramanyam A; Braimah IZ; Dhami A; Sachdev P; Mansour A; Chhablani J
Semin Ophthalmol; 2020 Jan; 35(1):2-6. PubMed ID: 31690175
[No Abstract] [Full Text] [Related]
39. Outer Retinal Thickness and Fundus Autofluorescence in Geographic Atrophy.
Wang DL; Agee J; Mazzola M; Sacconi R; Querques G; Weinberg AD; Smith RT
Ophthalmol Retina; 2019 Dec; 3(12):1035-1044. PubMed ID: 31810572
[TBL] [Abstract][Full Text] [Related]
40. Long-term Choroidal Thickness Changes in Eyes With Drusenoid Pigment Epithelium Detachment.
Dolz-Marco R; Balaratnasingam C; Gattoussi S; Ahn S; Yannuzzi LA; Freund KB
Am J Ophthalmol; 2018 Jul; 191():23-33. PubMed ID: 29621509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]